FDAnews
www.fdanews.com/articles/142730-st-asaph-firm-secures-588-000-toward-new-cancer-drug-technology

St Asaph Firm Secures $588,000 Toward New Cancer Drug Technology

December 23, 2011
A biotechnology company secured more than $588,000 investment to develop cancer treatments. ADC Biotechnology, based in St Asaph, is developing “superior production technology” to support its new antibody drug production process.
Daily Post